Manufacturing

Articles

GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022. 

GE Builds Single-Use Kit Manufacturing Facility in Switzerland

The therapy is currently approved in the EU as a gene therapy for the treatment of patients 12 years and older with transfusion-dependent β-thalassemia.

apceth to Begin Commercially Manufacturing bluebird bio’s Gene Therapy Treatment

The deal was approved by the Federal Trade Commission following a 10-month investigation.

Roche Completes $4.3 Billion Acquisition of Spark Therapeutics After FTC Investigation

The acquisition aids in the expansion of the Astellas Focus Area approach, which involves the creation of medicines for diseases with high unmet medical needs by identifying combinations of biology, therapeutic modality and technology based on emerging science.

Astellas to Acquire Audentes for $3 Billion

Agnes Shanley is senior editor of Pharmaceutical Technology.

Aiming to break the bottlenecks that are slowing commercialization of innovative therapies, a new $50-million center in Boston will develop both cell and viral vector products within a single facility.


New Center Marks Aggressive Push into CGMP Manufacturing of Cell and Gene Therapies

Fujifilm Diosynth Biotechnologies will add a new building, including gene therapy laboratories, to its facility in College Station, TX.

Fujifilm Expands Gene Therapy CDMO Capacity

Lonza and Cryoport have partnered up to strengthen Lonza’s ‘vein-to-vein’ delivery network by removing supply chain hurdles faced by developers of personalized therapeutics.

Lonza, Cryoport Partner in Cell and Gene Therapy Field

A number of experts will be examining investment opportunities within the evolving cell and gene therapy sector, in a panel discussion on Wednesday morning (Nov. 6, 2019) during CPhI Worldwide in Frankfurt, Germany.

Investing in Cell and Gene Technology

Under the agreement, gene and cell therapy companies can go directly to Aldevron for NTC’s technology without acquiring a license from NTC.

Aldveron and Nature Technology Corporation Collaborate to Offer Gene Therapy Services

The long-term agreement gives CombiGene the authority to manufacture and commercialize the drug if it is approved after clinical studies.

Manufacturing, Gene Therapies